A history of mild liver disease is associated with a higher risk for bleeding during anticoagulation therapy but does not change the relative efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation.
Hannah DellabellaContributing Writer
Hannah Dellabella is a freelance writer for Haymarket Media. She holds an MFA in creative writing from Purdue University and a BA in creative writing and professional writing from Carnegie Mellon University. Previously, she was the associate editor for Clinical Advisor at Haymarket Media and an assistant editor for the Haymarket Medical Network. In addition to being a medical writer, Hannah is a poet whose work has appeared in various literary journals.